Home > Insider Trading > Filing (0001610717-23-000279)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1676725	Ideaya Biosciences Inc.	IDYA	Pharmaceutical Preparations (2834)	474268251

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1790865	Jason Throne	C/O Ideaya Biosciences, Inc. 7000 Shoreline Court, Suite 350 South San Francisco CA 94080	Chief Legal Officer	No	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2023-09-12	1,000	$12.86	1,000	No	4	M	Direct
Common Stock	Disposition	2023-09-12	500	$30.00	500	No	4	S	Direct
Common Stock	Disposition	2023-09-12	500	$30.01	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2023-09-12	1,000	$0.00	1,000	$12.86

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
53,913		2032-02-29	No	4	M	Direct

Footnotes

The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted on March 29, 2023.
25% of the shares subject to the option vest on the first anniversary measured from January 1, 2022 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest monthly thereafter, such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.